Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.
Ntanasis-Stathopoulos I, Filippatos C, Gavriatopoulou M, Malandrakis P, Eleutherakis-Papaiakovou E, Spiliopoulou V, Syrigou RE, Theodorakakou F, Fotiou D, Migkou M, Roussou M, Kastritis E, Dimopoulos MA, Terpos E.
Ntanasis-Stathopoulos I, et al. Among authors: filippatos c.
Diseases. 2023 Sep 18;11(3):123. doi: 10.3390/diseases11030123.
Diseases. 2023.
PMID: 37754319
Free PMC article.